Potential conflict of interest: Nothing to report.
Decreased risk of liver cancer with thiazolidinediones therapy in patients with type 2 diabetes: Results from a meta-analysis
Article first published online: 15 FEB 2013
Copyright © 2013 American Association for the Study of Liver Diseases
Volume 58, Issue 2, pages 835–836, August 2013
How to Cite
Wang, F., Zhao, S.-Z., Zhang, M.-Y., Ma, Y.-L., Zhang, P. and Qin, H.-L. (2013), Decreased risk of liver cancer with thiazolidinediones therapy in patients with type 2 diabetes: Results from a meta-analysis. Hepatology, 58: 835–836. doi: 10.1002/hep.26259
Supported by grants Shanghai Natural Science Foundation of China (Grant No. 12ZR1447500), and State Key Program of National Natural Science of China (Grant No. 81230057).
- Issue published online: 29 JUL 2013
- Article first published online: 15 FEB 2013
- Accepted manuscript online: 16 JAN 2013 10:56AM EST
- Manuscript Accepted: 8 NOV 2012